State Research Institute of CIrculation Pathology
Novosibirsk, 630055, Russia
NCT Number: NCT01703247
The investigators have conducted a prospective, double-blind, randomized study to assess the comparative safety and efficacy of two different ablation strategies, PVI plus linear lesions (LL) versus PVI plus GP ablation, in patients with persistent or longstanding persistent AF. Results were assessed after follow-up of at least 3 years with the use of an implanted monitoring device (IMD).
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Phase 2
Novosibirsk, 630055, Russia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 years
Meshalkin Research Institute of Pathology of Circulation
Network
Ganglionated Plexi Ablation vs Linear Ablation in Patients Undergoing Pulmonary Vein Isolation for Persistent/Longstanding Persistent Atrial Fibrillation: A Randomized Comparison
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05458648
Arrhythmias, Cardiac, Atrial Fibrillation
New York, United States
View Trial DetailsNCT03907982
Arrhythmias, Cardiac, Atrial Fibrillation
London, United Kingdom
View Trial DetailsNCT06260670
Arrhythmias, Cardiac, Atrial Fibrillation
Bad Oeynhausen, North Rhine-Westphalia, Germany
View Trial DetailsNCT03882021
Arrhythmias, Cardiac, Atrial Fibrillation
Linz, UPR AUS, Austria
View Trial Details